|
|
Volumn 30, Issue 1, 2010, Pages 40-53
|
|
New therapeutic strategies for renal cell carcinoma.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
BENZENESULFONIC ACID DERIVATIVE;
BEVACIZUMAB;
DRUG DERIVATIVE;
EVEROLIMUS;
INDOLE DERIVATIVE;
MAMMALIAN TARGET OF RAPAMYCIN;
MONOCLONAL ANTIBODY;
PAZOPANIB;
PROTEIN KINASE INHIBITOR;
PROTEIN SERINE THREONINE KINASE;
PYRIDINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
PYRROLE DERIVATIVE;
RAPAMYCIN;
SIGNAL PEPTIDE;
SORAFENIB;
SULFONAMIDE;
SUNITINIB;
TEMSIROLIMUS;
ARTICLE;
DRUG ANTAGONISM;
DRUG APPROVAL;
DRUG MONITORING;
EPIDEMIOLOGY;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
KIDNEY CARCINOMA;
KIDNEY TUMOR;
NURSE ATTITUDE;
NURSING;
ONCOLOGY NURSING;
PATIENT COMPLIANCE;
PATIENT EDUCATION;
UNITED STATES;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
BENZENESULFONATES;
CARCINOMA, RENAL CELL;
CAUSALITY;
DRUG APPROVAL;
DRUG MONITORING;
HUMANS;
INDOLES;
INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS;
KIDNEY NEOPLASMS;
MEDICATION ADHERENCE;
NURSE'S ROLE;
ONCOLOGIC NURSING;
PATIENT EDUCATION AS TOPIC;
PROTEIN KINASE INHIBITORS;
PROTEIN-SERINE-THREONINE KINASES;
PYRIDINES;
PYRIMIDINES;
PYRROLES;
SIROLIMUS;
SULFONAMIDES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
MLCS;
MLOWN;
|
|
EID: 77952472196
PISSN: 1053816X
EISSN: None
Source Type: Journal
DOI: 10.7257/1053-816x.2010.30.1.40 Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
